What is Lenalidomide?

Category: Prescription Drugs

Most popular types: Revlimid

false

See also: Bortezomib-lenalidomide-dexamethasone (VRd) Carfilzomib-lenalidomide-dexamethasone Cyclophosphamide-lenalidomide-dexamethasone Lenalidomide-bendamustine-dexamethasone Lenalidomide-dexamethasone (Rd) Melphalan-prednisone-lenalidomide (MPL)

Lenalidomide is an oral anticancer agent that may be used for the treatment of myelodysplastic syndrome (MDS), mantle cell lymphoma, and for the treatment of multiple myeloma.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Multiple myeloma 140 133
Kaposi's sarcoma 2 1
Myelodysplastic syndrome 2 1
Non-Hodgkin's lymphoma 1 2
Participate in clinical trial 1 1
POEMS syndrome 1 1

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 14
Moderate 56
Mild 48
None 19

Commonly reported side effects and conditions associated with Lenalidomide

Side effect Patients
Diarrhea 27
Fatigue 24
Tiredness 6
Low white blood cell count (leukopenia) 4
Rashes (redness, swelling) 4
Constipation 3

Show all 79 reported side effects

Dosages

Based on patients currently taking Lenalidomide

Dosage Patients
10 mg daily 23
25 mg daily 12
15 mg daily 7
5 mg daily 4
25 mg every 3 weeks 2
5 mg every 3 weeks 1
10 mg every 3 weeks 1
10 mg every other week 1
10 mg m,w,f 1
35 mg daily 1

See all 14 dosages

Why patients stopped taking Lenalidomide

Multiple reasons could be selected

Reason Patients
Side effects too severe 12
Doctor's advice 10
Did not seem to work 8
Course of treatment ended 7
Other 3
See all 34 patients who've stopped taking Lenalidomide

Duration

Currently taking Lenalidomide

Duration Patients
1 - 6 months 1
6 months - 1 year 2
1 - 2 years 13
2 - 5 years 27
5 - 10 years 14
10 years or more 2

Stopped taking Lenalidomide

Duration Patients
Less than 1 month 9
1 - 6 months 9
6 months - 1 year 5
1 - 2 years 5
2 - 5 years 6
Adherence
Adherence Evaluations
Always 129
Usually 5
Sometimes 0
Never taken as prescribed 3
Burden
Burden Evaluations
Very hard to take 5
Somewhat hard to take 15
A little hard to take 16
Not at all hard to take 101
Cost per month
Cost per month Evaluations
$200+ 17
$100-199 5
$50-99 7
$25-49 22
< $25 52
Not specified 34

What people switch to and from

Patients started taking Lenalidomide after stopping:

Treatment Patients
Bortezomib (Velcade) 8
Bortezomib-lenalidomide-dexamethasone (VRd) 4
Bortezomib-dexamethasone (Vd) 2
Lenalidomide-dexamethasone (Rd) 2
Thalidomide 2

Show all 8 treatments patients report switching from

Patients stopped taking Lenalidomide and switched to:

Treatment Patients
Bortezomib (Velcade) 4
Pomalidomide-dexamethasone 4
Carfilzomib (Kyprolis) 3
Ixazomib (Ninlaro) 3
Pomalidomide (Pomalyst) 3

Show all 12 treatments patients report switching to

Last updated:

1 patient evaluation for Lenalidomide

Feb 4, 2016 (Started Feb 01, 2016)

  • Effectiveness
    Major (for non-Hodgkin's lymphoma)
  • Side effects
    Severe (itchy scalp, fluid retention (edema), chest pain, breathing difficulty, heart palpitations)
  • Adherence
    Always
  • Burden
    Very hard to take
Dosage: 20 mg Daily
Advice & Tips: Don't touch this stuff!
Cost: $50-99 monthly

Feb 1, 2016 (Started Feb 01, 2016)

  • Effectiveness
    Can't tell (for non-Hodgkin's lymphoma)
  • Side effects
    Severe
  • Adherence
    Always
  • Burden
    Very hard to take
Dosage: 20 mg Daily
Cost: $50-99 monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Lenalidomide